LRRFIP2靶向药基因

基因名称:LRRFIP2  (LRR binding FLII interacting protein 2)

别名: HUFI-2
基因ID:9209
Chromosome(GRCh37) :3 Start: 37094117 End: 37217992 Strand:
信号通路:
靶向药:
化疗药:

简介:该基因编码的蛋白与myd88结合在toll样受体4(tlr4)的胞浆末端,从而激活核因子kappa b信号传导。泛素样蛋白fat10阻止编码蛋白与tlr4的相互作用,从而使核因子kappa b信号途径失活。此外,这种蛋白可以通过将caspase-1抑制剂flightless-i招募到炎症复合物中来下调nlrp3炎症。[由RefSeq提供,2017年1月]The protein encoded by this gene, along with MYD88, binds to the cytosolic tail of toll-like receptor 4 (TLR4), which results in activation of nuclear factor kappa B signaling. The ubiquitin-like protein FAT10 prevents the interaction of the encoded protein and TLR4, thereby inactivating the nuclear factor kappa B signaling pathway. In addition, this protein can downregulate the NLRP3 inflammasome by recruiting the caspase-1 inhibitor Flightless-I to the inflammasome complex. [provided by RefSeq, Jan 2017]
LRRFIP2突变与药物:

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务